Anesthesia and Respiratory Devices Market to Reach US$109.07 Billion by 2035, Driven by Rising Surgical Procedures and Respiratory Disorders

The global Anesthesia and Respiratory Devices Market reached US$57.56 billion in 2025 and is expected to reach US$109.07 billion by 2035, growing at a CAGR of 6.6% during the forecast period 2026-2035. The market is being reshaped by the convergence of perioperative care, respiratory support, remote monitoring, and connected medical devices, with demand extending from operating rooms to intensive-care units and home healthcare. Rising surgical volumes, increasing respiratory disorders such as COPD and asthma, aging populations, and the need for continuous respiratory monitoring are creating sustained demand for anesthesia machines, ventilators, oxygen delivery systems, airway management devices, and advanced patient-monitoring technologies. A notable shift is the integration of cellular connectivity and remote patient monitoring, exemplified by Prevounce Health's August 2024 launch of the Pylo OX1-LTE blood oxygen device, designed for connected monitoring of patients with chronic respiratory conditions.

The next growth wave is being driven by AI-enabled ventilation, smart anesthesia systems, portable respiratory devices, and digitally connected monitoring platforms. Manufacturers are increasingly investing in technologies that can automatically adjust ventilation parameters, detect respiratory deterioration, improve anesthesia delivery, and transmit patient data to clinicians remotely. This is creating opportunities across hospitals, ambulatory surgical centers, emergency care, and home-based respiratory management. With healthcare providers prioritizing safer anesthesia, personalized respiratory support, lower ICU workloads, and continuous patient monitoring, the market is moving from standalone equipment toward integrated, intelligent respiratory and perioperative care ecosystems-making it a high-potential segment within the broader medical devices industry.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://www.datamintelligence.com/download-sample/anesthesia-and-respiratory-devices-market?sai-v

Recent Developments
June 2026: Dräger continued advancing its anesthesia workstation portfolio with integrated ventilation, gas monitoring, and connected clinical information capabilities. Its Atlan platform supports lung-protective ventilation and low- and minimal-flow anesthesia, reflecting growing adoption of integrated and digitally connected operating-room technologies.

May 2026: GE HealthCare continued strengthening its anesthesia and respiratory care portfolio, focusing on integrated patient monitoring, ventilation, and perioperative workflow technologies across North America and Europe. The expansion supports hospitals seeking greater interoperability and more efficient anesthesia management.

April 2026: Philips advanced its connected respiratory-care technologies across Europe and Asia-Pacific, supporting continuous respiratory monitoring, connected patient data, and improved clinical decision-making in critical-care and hospital environments.

March 2026: Mindray entered the North American ventilator market with the SV900 and SV700 ventilators, expanding its critical-care portfolio and offering adaptable ventilation technologies for acute-care hospitals. The launch strengthens competition in the respiratory devices segment and supports demand for advanced mechanical ventilation systems.

February 2026: Medtronic continued expanding its respiratory and patient-monitoring technologies across North America and Europe, emphasizing connected monitoring, respiratory care, and technologies designed to support clinicians in critical-care and perioperative settings.

Key Players
GE HealthCare | Medtronic | Koninklijke Philips N.V. | Drägerwerk AG & Co. KGaA | Teleflex Incorporated | Getinge AB | Smiths Group plc | Fisher & Paykel Healthcare Limited | ResMed | Inogen, Inc. | Others

Key Highlights
GE HealthCare - Holds a 20.4% share, driven by its comprehensive anesthesia workstations, respiratory care systems, patient monitoring technologies, and integrated critical care solutions.

Medtronic - Holds a 18.2% share, supported by its mechanical ventilation systems, anesthesia and airway management technologies, respiratory monitoring devices, and extensive global healthcare presence.

Koninklijke Philips N.V. - Holds a 15.6% share, strengthened by its sleep and respiratory care portfolio, non-invasive ventilation systems, patient monitoring technologies, and connected healthcare solutions.

Drägerwerk AG & Co. KGaA - Holds a 12.8% share, fueled by its anesthesia workstations, ventilators, respiratory monitoring systems, and intensive care technologies.

Teleflex Incorporated - Holds a 9.7% share, driven by its airway management products, respiratory devices, anesthesia solutions, and critical care technologies.

Getinge AB - Holds a 7.1% share, supported by its anesthesia systems, ventilators, critical care equipment, and integrated operating room solutions.

Smiths Group plc - Holds a 5.6% share, strengthened by its airway management devices, breathing circuits, anesthesia products, and specialized respiratory care technologies.

Fisher & Paykel Healthcare Limited - Holds a 4.8% share, driven by its respiratory humidification systems, non-invasive ventilation products, nasal high-flow therapy, and sleep apnea solutions.

ResMed - Holds a 3.9% share, fueled by its CPAP and non-invasive ventilation systems, sleep-disordered breathing technologies, digital health platforms, and connected respiratory care solutions.

Inogen, Inc. - Holds a 1.1% share, supported by its portable oxygen concentrators, lightweight oxygen therapy systems, and home-based respiratory care solutions.

Others - Hold a combined 0.8% share, comprising emerging respiratory technology companies and specialized healthcare innovators.

Emerging Players
Aerin Medical - Focuses on minimally invasive nasal airway technologies and innovative solutions for patients with nasal obstruction and related respiratory conditions.

Circadia Health - Develops remote respiratory and chronic-care monitoring technologies, leveraging connected devices and digital health analytics to support home-based patient management.

SeaStar Medical - Focuses on extracorporeal blood purification technologies designed to address inflammatory conditions and support patients with severe critical-care needs.

Get the Full Report Here: https://www.datamintelligence.com/buy-now-page?report=anesthesia-and-respiratory-devices-market?sai-v

Market Drivers
Rising prevalence of COPD, asthma, sleep apnea, and other respiratory disorders, along with increasing surgical procedures, is driving market growth.

Growing adoption of ventilators, oxygen concentrators, anesthesia machines, nebulizers, and patient-monitoring systems is accelerating demand.

Advancements in connected devices, AI-enabled monitoring, portable respiratory equipment, and digital anesthesia systems are improving patient safety and clinical efficiency.

Market Opportunities
Growing demand for home-based respiratory care, portable oxygen systems, and remote patient monitoring is creating new opportunities.

Increasing investments in smart hospitals, critical-care infrastructure, and advanced anesthesia workstations are expanding market potential.

Integration of AI, IoT, cloud connectivity, and predictive analytics is enabling smarter respiratory and anesthesia management.

Rising healthcare investments in emerging economies, particularly across Asia Pacific, are creating additional growth opportunities.

Industry Developments
AI-enabled respiratory monitoring, connected anesthesia systems, advanced ventilators, and portable respiratory devices are transforming the market.

Digital connectivity and remote monitoring are improving respiratory-care management and workflow efficiency.

2026: Healthcare Foresights reported continued market expansion, with global revenue expected to reach US$60.5 billion in 2026 and US$100.5 billion by 2035.

Product launches, technology upgrades, strategic partnerships, and investments in respiratory-care infrastructure are strengthening competition.

Regional Insights
North America 30.0% share: Leads the market due to advanced healthcare infrastructure, high healthcare expenditure, strong adoption of respiratory technologies, and a large number of surgical procedures.

Europe: Growth is supported by established healthcare infrastructure, an aging population, increasing respiratory diseases, and rising adoption of advanced ventilatory support.

Asia Pacific: Fastest-growing region, driven by expanding healthcare infrastructure, rising respiratory disease prevalence, growing patient populations, and increasing healthcare investments.

Latin America: Growth is supported by improving healthcare access, expanding hospital infrastructure, and increasing demand for respiratory and anesthesia equipment.

Middle East & Africa: Rising healthcare modernization, hospital construction, and investments in advanced respiratory and critical-care technologies are supporting market growth.

Speak to our analyst and get customization in the report as per your requirements: https://www.datamintelligence.com/customize/anesthesia-and-respiratory-devices-market?sai-v

Key Segments
➥ By Respiratory Equipment

Ventilators: Represents the dominant segment, driven by increasing prevalence of respiratory disorders, rising critical care admissions, and growing demand for invasive and non-invasive mechanical ventilation.

Oxygen Concentrators: Represents a significant segment, supported by increasing demand for supplemental oxygen therapy in hospitals, homecare settings, and long-term respiratory care.

Nebulizers: Represents a major segment, fueled by the growing prevalence of asthma, COPD, and other respiratory conditions requiring inhaled medication delivery.

CPAP & BiPAP Devices: Represents a rapidly growing segment, driven by rising prevalence of sleep apnea and increasing adoption of non-invasive respiratory support.

Others: Represents a moderate segment, supported by expanding use of respiratory support and therapy equipment across critical care, emergency care, and homecare settings.

➥ By Respiratory Disposables

Airway Management Products: Represents the dominant segment, driven by widespread use of endotracheal tubes, tracheostomy tubes, laryngeal mask airways, and other airway management products during respiratory care and anesthesia procedures.

Breathing Circuits: Represents a significant segment, supported by their essential role in delivering oxygen and anesthetic gases while maintaining effective respiratory support.

Masks: Represents a major segment, fueled by increasing adoption of oxygen masks, nebulizer masks, CPAP masks, and other interfaces for non-invasive respiratory therapy.

Others: Represents a moderate segment, driven by continued demand for filters, humidifiers, connectors, catheters, and other disposable respiratory accessories.

➥ By Respiratory Measurement Devices

Pulse Oximeters: Represents the dominant segment, driven by widespread use for continuous monitoring of blood oxygen saturation across hospitals, emergency care, homecare, and ambulatory settings.

Spirometers: Represents a significant segment, supported by increasing diagnosis and monitoring of asthma, COPD, and other pulmonary function disorders.

Peak Flow Meters: Represents a growing segment, fueled by increasing use in asthma management and home-based respiratory monitoring.

Others: Represents a moderate segment, supported by adoption of capnographs, respiratory gas analyzers, and other devices used to assess respiratory function and gas exchange.

➥ By Anesthesia Machines

Anesthesia Workstations: Represents the dominant segment, driven by increasing surgical volumes and growing demand for integrated anesthesia delivery, ventilation, and patient monitoring capabilities.

Anesthesia Delivery Machines: Represents a significant segment, supported by their essential role in accurately delivering anesthetic gases and maintaining controlled ventilation during surgical procedures.

Anesthesia Ventilators: Represents a major segment, fueled by increasing adoption of advanced ventilation technologies that provide precise respiratory support during anesthesia.

Others: Represents a moderate segment, driven by demand for anesthesia vaporizers, gas delivery systems, breathing systems, and related equipment.

➥ By End User

Hospitals: Represents the dominant segment, driven by high surgical volumes, increasing critical care admissions, advanced respiratory care infrastructure, and widespread use of anesthesia equipment.

Ambulatory Surgical Centers (ASCs): Represents a significant segment, supported by the growing number of outpatient and minimally invasive surgical procedures requiring modern anesthesia and respiratory devices.

Homecare Settings: Represents a rapidly growing segment, fueled by increasing preference for home-based respiratory care, rising chronic respiratory disease prevalence, and expanding adoption of portable oxygen and ventilation devices.

Specialty Clinics: Represents a growing segment, driven by increasing diagnosis and management of pulmonary, sleep, and other respiratory conditions in specialized healthcare facilities.

Emergency Medical Services (EMS): Represents a significant segment, supported by the need for portable respiratory and anesthesia-related equipment for emergency response, patient stabilization, and medical transportation.

Others: Represents a moderate segment, encompassing diagnostic centers, long-term care facilities, rehabilitation centers, and other healthcare settings requiring respiratory and anesthesia equipment.

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.